PMV Pharmaceuticals, Inc. (PMVP)
1.70
+0.33
(+24.09%)
USD |
NASDAQ |
Feb 27, 16:00
1.66
-0.04
(-2.35%)
After-Hours: 20:00
PMV Pharmaceuticals EPS Diluted (Quarterly) : -0.3974 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Aclaris Therapeutics, Inc. | -0.1614 |
| Atea Pharmaceuticals, Inc. | -0.5319 |
| Instil Bio, Inc. | -2.011 |
| Alumis, Inc. | -1.064 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.06M |
| Total Expenses (Quarterly) | 21.06M |
| Enterprise Value | -37.86M |
| Earnings Yield | -93.16% |
| Normalized Earnings Yield | -93.16 |